Navigation Links
ER Visits Tied to Ambien on the Rise
Date:5/1/2013

WEDNESDAY, May 1 (HealthDay News) -- There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.

Adverse reactions to zolpidem -- the active ingredient in the sleep aids Ambien, Ambien CR, Edluar and Zolpimist -- rose almost 220 percent between 2005 and 2010, researchers from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) found.

The study authors concluded that use of these drugs for the short-term treatment of insomnia should be carefully monitored. Zolpidem, which has been approved by the U.S. Food and Drug Administration, has been used safely and effectively by millions of Americans, but adverse reactions to the medication have increased. Most of these cases involved people aged 45 and older, the researchers said.

"Although short-term sleeping medications can help patients, it is exceedingly important that they be carefully used and monitored," SAMHSA administrator Pamela Hyde said in an agency news release. "Physicians and patients need to be aware of the potential adverse reactions associated with any medication, and work closely together to prevent or quickly address any problems that may arise."

Possible adverse reactions from medications containing zolpidem include:

  • Daytime drowsiness
  • Dizziness
  • Hallucinations
  • Agitation
  • Sleep-walking
  • Drowsiness while driving

After analyzing findings from a public health surveillance system that monitors drug-related illnesses and deaths, the researchers found that emergency-room cases involving medications such as Ambien increased sharply from about 6,000 in 2005 to more than 19,000 in 2010.

Women were more often affected than men. The findings revealed that during the study time frame, there was a 274 percent increase in the number of women who went to the emergency room due to a reaction involving zolpidem, compared to a 144 percent increase among men. In 2010 alone, women accounted for 68 percent of all trips to the emergency room for an adverse reaction related to zolpidem, the researchers said.

The study authors also noted that adverse reactions to these sleep aids could be worsened when the medication is taken with other substances, such as certain anti-anxiety drugs and narcotic pain relievers.

The SAMHSA report said that in 2010, half of all emergency-room visits related to zolpidem involved its interaction with other drugs. Moreover, 37 percent of all emergency visits resulted from the combination of these sleep aids and drugs that depress the central nervous system.

In response to the increase in adverse reactions, in January 2013 the FDA required drug manufacturers to cut the recommended dose for women in half. The FDA also recommended that drug companies reduce the dosage for men.

More information

The U.S. National Institutes of Health has more about zolpidem.

-- Mary Elizabeth Dallas

SOURCE: U.S. Substance Abuse and Mental Health Services Administration, news release, May 1, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Into Action Drug Treatment Center Visits the Arts Garage in Delray Beach, Florida
2. Doctors not informed of harmful effects of medicines during sales visits
3. Rep. Tammy Duckworth Visits Etymotic Research
4. Charges for emergency room visits often based on incorrect assumptions
5. Bathroom Visits May Add to Sleep Problems for Seniors
6. Costs of ER Visits Vary in U.S., Study Finds
7. Governor Inslee Visits General Plastics to Encourage Veteran Employment
8. Gulfside Dental Visits First Steps Daycare in Beaumont, TX
9. ER Visits Linked to ADHD Meds Up Sharply
10. Sesame Street Live's Super Grover Visits WHEDco in the South Bronx to Teach Low-Income Children What it Takes to be a Super Hero
11. Free clinics reduce emergency department visits
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ER Visits Tied to Ambien on the Rise
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology: